combination REOLYSIN

Related by string. * combina tion . Combinations . COMBINATION . combinations . Combination : toe loop combination . Midland Combination . combination fen phen . Pru AIA combination . combinations thereof Everywhere / Reolysin : successfully commercialize REOLYSIN . REOLYSIN ® . intravenous REOLYSIN . examining REOLYSIN * combination REOLYSIN R . Combination REOLYSIN R *

Related by context. Frequent words. (Click for all words.) 54 Phase 1b clinical 54 Amrubicin 53 phase IIa 53 IIa clinical trial 53 Phase Ia 51 multicenter clinical 51 Pivotal Phase III 51 Reolysin 51 phase 2a 50 Phase III 50 Phase 1a 50 phase IIb 50 dose escalation trial 50 TASQ 50 Phase 1b trial 50 Phase III pivotal 49 Phase Ib 49 Phase 2a clinical 49 tanespimycin 49 confirmatory Phase III 49 TG# [001] 49 registrational 49 pivotal Phase 49 randomized Phase III 48 Phase IIb clinical 48 Pivotal Trial 48 clinical trial 48 Phase 1b 48 Phase 2a 48 Phase II 48 multicentre 48 ASA# 48 Alpharadin 47 Azedra 47 pivotal Phase III 47 Phase 47 Phase 2a trial 47 pharmacokinetic studies 47 evaluable patients 47 placebo controlled clinical 47 axitinib 47 Allovectin 7 R 47 nab paclitaxel 47 Clinical Trial Results 47 Nimotuzumab 46 dose escalation study 46 Phase IIa clinical 46 placebo controlled randomized 46 Phase III clinical 46 Asentar 46 Phase 2b study 46 dose escalation 46 Phase 2b trial 46 glufosfamide 46 xenograft models 46 Amigal 46 romidepsin 46 Phase IIa trial 46 double blinded placebo 45 HGS ETR1 45 dosimetry 45 Phase 2b 45 blinatumomab 45 randomized Phase 45 Phase IIb 45 prospective randomized controlled 45 IMC A# 45 relapsed refractory multiple myeloma 45 TELCYTA 45 NSABP 45 ozarelix 45 AP# [003] 45 Phase III randomized 45 eniluracil 45 subgroup analyzes 45 randomized clinical 45 Atiprimod 45 Phase III Trial 45 RG# [001] 45 blinded placebo controlled 45 Mylotarg 44 Phase 2b clinical 44 Telcyta 44 tesmilifene 44 Phase III clinical trials 44 Phase IIa clinical trials 44 Investigational Device Exemption IDE 44 clinical trials 44 Phase IIb trial 44 pharmacokinetic profiles 44 Investigational Device Exemption 44 dose cohorts 44 INCB# [002] 44 ProLindac 44 ATTRACT 44 multicenter randomized 43 prospective randomized 43 IMGN# 43 TOCOSOL Paclitaxel 43 EPC# 43 XL# [003]

Back to home page